Lantheus Holdings Inc (LNTH) support and resistance · P/E 23, rev $765.5M
Lantheus Holdings Inc (LNTH) is a drug manufacturers - specialty & generic company listed on US.
This page maps Lantheus Holdings Inc (LNTH) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LNTH revenue for 2026-06-30 was $765.5M. Net income was $193.4M. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
LNTH currently screens at market cap $5.56B and trailing P/E 22.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LNTH 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LNTH quote page for the session range and the stock page for the full model.
Not investment advice.